Market Overview:
The global clinical diagnostics market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of chronic diseases, rising demand for personalized medicine, and technological advancements in diagnostic instruments and reagents. By product, the global clinical diagnostics market is segmented into instruments, reagents, and others. The instruments segment accounted for the largest share of the global clinical diagnostics market in 2017 and is projected to grow at a CAGR of 7% from 2018 to 2030. This growth can be attributed to the increasing demand for advanced diagnostic equipment such as next-generation sequencing (NGS) systems and molecular diagnostics platforms.
Product Definition:
Clinical diagnostics is the process of identifying and diagnosing diseases in patients. It is an important part of medicine, as it allows doctors to treat patients effectively.
Global Clinical Diagnostics Market Size Growth Rate by Product: 2016 VS 2021 VS 2027:
Global clinical diagnostics market was valued at USD 93.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.0% from 2021 to 2027. The market is majorly driven by the growing prevalence of chronic diseases, technological advancements, increasing demand for point-of-care testing (POCT), and rising government initiatives pertaining to the introduction of technologically advanced products in developing countries such as India and China.
Instruments:
Instruments and it's usage in clinical diagnostics market is used for the purpose of detection, measurement, monitoring or therapy of disease or condition. It helps medical practitioners to diagnose the diseases accurately and provides accurate results. The global instruments and it's usage in clinical diagnostics market is segmented on the basis of product into consumables & reagents, devices & equipment and services.
Application Insights:
The hospital segment dominated the global market in terms of revenue in 2018. The increasing prevalence of chronic diseases, such as cancer, diabetes and cardiovascular diseases along with rising number of hospital admissions is expected to drive the demand for clinical diagnostics at a global level over the forecast period.
Increasing investments by governments across countries to improve healthcare infrastructure are also likely to contribute towards segment growth during the study period. For instance, according to WHO data published in 2019, USD 250 billion needs to be invested annually for healthcare facilities and equipment worldwide. This investment is expected to create approximately 9 million new jobs globally by 2030 which may further propel industry growth over next eight years or so. (Growth In Investments Needed To Maintain Healthcare Infrastructure Worldwide).
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. The presence of well-established healthcare infrastructure, high awareness levels coupled with relatively higher disposable income are some factors attributing to its large share. Moreover, increasing R&D investments by companies and government for developing advanced diagnostic techniques is expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising medical tourism and improving healthcare infrastructure in emerging countries such as India, China and Japan. In addition, growing target population base along with an increase in per capita income will boost demand further over this period. Furthermore, favorable government initiatives for instance; “Make in India†campaign by Indian Government which includes manufacturing sector expansion within country will propel industry growth over next eight years thus creating a huge opportunity for Global Clinical Diagnostics Market players operating within Asia Pacific region.
Growth Factors:
- Increasing incidence of lifestyle diseases such as diabetes and heart diseases is expected to drive the demand for clinical diagnostics over the forecast period.
- Rising geriatric population is also anticipated to boost the market growth as this population is more susceptible to various chronic diseases.
- Technological advancements in diagnostic equipment are likely to propel the market growth as they offer improved accuracy and efficiency in diagnosis.
- Growing public-private investments for development of novel diagnostic technologies will provide lucrative opportunities for market players over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Clinical Diagnostics Market Research Report
By Type
Global Clinical Diagnostics Market Size Growth Rate by Product: 2016 VS 2021 VS 2027, Instruments, Reagents, Others
By Application
Hospital, Clinic, Others
By Companies
Siemens Healthcare, Sonic Healthcare, Charles River Laboratories, Quest Diagnostics, Bioscientia Healthcare, Bio-Reference Laboratories, ARUP Laboratories, Abbott Laboratories, Labco, Healthscope, Laboratory Corporation Of America Holdings, Qiagen, Genoptix Medical Laboratory, Genzyme, Clarient
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
203
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Clinical Diagnostics Market Report Segments:
The global Clinical Diagnostics market is segmented on the basis of:
Types
Global Clinical Diagnostics Market Size Growth Rate by Product: 2016 VS 2021 VS 2027, Instruments, Reagents, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Siemens Healthcare
- Sonic Healthcare
- Charles River Laboratories
- Quest Diagnostics
- Bioscientia Healthcare
- Bio-Reference Laboratories
- ARUP Laboratories
- Abbott Laboratories
- Labco
- Healthscope
- Laboratory Corporation Of America Holdings
- Qiagen
- Genoptix Medical Laboratory
- Genzyme
- Clarient
Highlights of The Clinical Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Global Clinical Diagnostics Market Size Growth Rate by Product: 2016 VS 2021 VS 2027
- Instruments
- Reagents
- Others
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clinical Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Clinical diagnostics is the application of diagnostic methods to assess and diagnose diseases in humans. Clinical diagnostics includes laboratory tests, such as blood tests and urine tests, as well as imaging techniques such as X-rays and CT scans.
Some of the major companies in the clinical diagnostics market are Siemens Healthcare, Sonic Healthcare, Charles River Laboratories, Quest Diagnostics, Bioscientia Healthcare, Bio-Reference Laboratories, ARUP Laboratories, Abbott Laboratories, Labco, Healthscope, Laboratory Corporation Of America Holdings, Qiagen, Genoptix Medical Laboratory, Genzyme, Clarient.
The clinical diagnostics market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Clinical Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Clinical Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Clinical Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Clinical Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Clinical Diagnostics Market Size & Forecast, 2020-2028
4.5.1 Clinical Diagnostics Market Size and Y-o-Y Growth
4.5.2 Clinical Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Global Clinical Diagnostics Market Size Growth Rate by Product: 2016 VS 2021 VS 2027
5.2.2 Instruments
5.2.3 Reagents
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Clinical Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Clinical Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Global Clinical Diagnostics Market Size Growth Rate by Product: 2016 VS 2021 VS 2027
9.6.2 Instruments
9.6.3 Reagents
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Global Clinical Diagnostics Market Size Growth Rate by Product: 2016 VS 2021 VS 2027
10.6.2 Instruments
10.6.3 Reagents
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Global Clinical Diagnostics Market Size Growth Rate by Product: 2016 VS 2021 VS 2027
11.6.2 Instruments
11.6.3 Reagents
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Global Clinical Diagnostics Market Size Growth Rate by Product: 2016 VS 2021 VS 2027
12.6.2 Instruments
12.6.3 Reagents
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Global Clinical Diagnostics Market Size Growth Rate by Product: 2016 VS 2021 VS 2027
13.6.2 Instruments
13.6.3 Reagents
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Clinical Diagnostics Market: Competitive Dashboard
14.2 Global Clinical Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Siemens Healthcare
14.3.2 Sonic Healthcare
14.3.3 Charles River Laboratories
14.3.4 Quest Diagnostics
14.3.5 Bioscientia Healthcare
14.3.6 Bio-Reference Laboratories
14.3.7 ARUP Laboratories
14.3.8 Abbott Laboratories
14.3.9 Labco
14.3.10 Healthscope
14.3.11 Laboratory Corporation Of America Holdings
14.3.12 Qiagen
14.3.13 Genoptix Medical Laboratory
14.3.14 Genzyme
14.3.15 Clarient
